Hawkins et al., 2022 - Google Patents
Potent bactericidal antimycobacterials targeting the chaperone ClpC1 based on the depsipeptide natural products ecumicin and ohmyungsamycin AHawkins et al., 2022
- Document ID
- 6902027671908285065
- Author
- Hawkins P
- Hoi D
- Cheung C
- Wang T
- Quan D
- Sasi V
- Liu D
- Linington R
- Jackson C
- Oehlers S
- Cook G
- Britton W
- Clausen T
- Payne R
- Publication year
- Publication venue
- Journal of medicinal chemistry
External Links
Snippet
Ohmyungsamycin A and ecumicin are structurally related cyclic depsipeptide natural products that possess activity against Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB). Herein, we describe the design and synthesis of a library of analogues …
- 108010047246 ecumicin 0 title abstract description 90
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hawkins et al. | Potent bactericidal antimycobacterials targeting the chaperone ClpC1 based on the depsipeptide natural products ecumicin and ohmyungsamycin A | |
| Carney et al. | Restriction of the conformational dynamics of the cyclic acyldepsipeptide antibiotics improves their antibacterial activity | |
| Giltrap et al. | Total synthesis of teixobactin | |
| Gallardo-Godoy et al. | Activity and predicted nephrotoxicity of synthetic antibiotics based on polymyxin B | |
| Rossiter et al. | Natural products as platforms to overcome antibiotic resistance | |
| Thornburg et al. | Apratoxin H and apratoxin A sulfoxide from the Red Sea cyanobacterium Moorea producens | |
| Bhandari et al. | The role of ClpP protease in bacterial pathogenesis and human diseases | |
| Malik et al. | Conformational control of the bacterial Clp protease by natural product antibiotics | |
| O'Connell et al. | Combating multidrug‐resistant bacteria: current strategies for the discovery of novel antibacterials | |
| Culp et al. | Bacterial proteases, untapped antimicrobial drug targets | |
| LaMarche et al. | Discovery of LFF571: an investigational agent for Clostridium difficile infection | |
| Hanna et al. | Discovery, synthesis, and optimization of peptide-based antibiotics | |
| Zhou et al. | Antimycobacterial rufomycin analogues from Streptomyces atratus strain MJM3502 | |
| Horswill et al. | Structure–activity relationship studies of small molecule modulators of the staphylococcal accessory gene regulator | |
| Dutta et al. | Mycobacterial protein tyrosine phosphatases A and B inhibitors augment the bactericidal activity of the standard anti-tuberculosis regimen | |
| Cui et al. | Synthesis and bioactivity investigation of the individual components of cyclic lipopeptide antibiotics | |
| Chen et al. | A marine antibiotic kills multidrug-resistant bacteria without detectable high-level resistance | |
| KR20150022911A (en) | Modulation of hepatitis b virus cccdna transcription | |
| Chow et al. | Methylation of daptomycin leading to the discovery of kynomycin, a cyclic lipodepsipeptide active against resistant pathogens | |
| Ding et al. | Oryzamides A–E, cyclodepsipeptides from the sponge-derived fungus Nigrospora oryzae PF18 | |
| Cheng et al. | Actinoramide A identified as a potent antimalarial from titration-based screening of marine natural product extracts | |
| Zhan et al. | Improvement of asparagine ethylenediamines as anti-malarial Plasmodium-selective proteasome inhibitors | |
| Yang et al. | A modular synthetic route involving N-aryl-2-nitrosoaniline intermediates leads to a new series of 3-substituted halogenated phenazine antibacterial agents | |
| Onda et al. | Conformation-based design and synthesis of apratoxin A mimetics modified at the α, β-unsaturated thiazoline moiety | |
| Sanguinetti et al. | Novel macrocyclic amidinoureas: Potent non-azole antifungals active against wild-type and resistant Candida species |